MIMs is challenging this deep-rooted a priori of time and financial losses with an augmented intelligence software that layers the drug manufacturer’s own proprietary patient data on MIMs ...

The year is 2030, you have been in the doctor's office for two hours, answering what seems like hundreds of questions on ...

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google DeepMind CEO Demis Hassabis suggested Tuesday.… Speaking on a panel at the ...